Skip to main content
SpringerLink
Log in

Serum Creatinine Trajectories in Kidney Disease

  • Reference work entry
  • First Online:
Biomarkers in Kidney Disease

Abstract

Creatinine is the end product of the metabolism of creatine phosphate, a by-product of skeletal muscle metabolism. It is excreted mainly via the kidneys, primarily by glomerular filtration. It is therefore the most widely used blood assay to measure the presence and progression of chronic kidney disease. The real-time monitoring of serum creatinine translations at the individual patent level, the so-called serum creatinine trajectories, offers a fascinating methodology of the study of kidney function and disease. In this review, we have examined and analyzed the serum creatinine trajectories in kidney disease, ranging from acute kidney injury (AKI) with its multifarious rainbow spectrum of renal outcomes in AKI, through the titillating vicissitudes of the different patterns of CKD to ESRD progression including a description of the syndrome of rapid-onset end-stage renal disease (SORO-ESRD) and the syndrome of late-onset renal failure from angiotensin blockade (LORFFAB) to the serum creatinine trajectories of some specific renal syndromes including adult polycystic kidney disease, HIV nephropathy, and sickle cell disease. These patients represent representative cases of the named renal states as managed at the Renal Unit of the Mayo Clinic Health System, Eau Claire, Northwestern Wisconsin, USA, and the Renal Clinic of Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. We surmise that the study of individual patient-level serum creatinine trajectories, an evolving area of current nephrology practice, can indeed provide additional diagnostic and prognostic insights in the management of the nephrology patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 449.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agaba EI, Agaba PA, Sirisena ND, Antenyi EA, Idoko JA. Renal disease in AIDS patients in North Central Nigeria. Niger J Med. 2003;12(3):120–5.

    CAS  PubMed  Google Scholar 

  • Allen PJ. Creatine metabolism and psychiatric disorders: does creatine supplementation have therapeutic value? Neurosci Biobehav Rev. 2012;36(5):1442–62. doi:10.1016/j.neubiorev.2012.03.005.PMC3340488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • American College of Physicians. Summaries for patients. Screening, monitoring, and treatment of early stage chronic kidney disease: recommendations from the American College of Physicians. Ann Intern Med. 2013;159:I–28. [PMID: 24146038 doi:10.7326/0003-4819-159-12-201312170-00728].

    Google Scholar 

  • American Society of Nephrology. ASN emphasizes need for early detection of kidney disease, a silent killer (Press Release, Oct 22 2013). Available from: URL: http://www.asn-online.org/news/2013/ASN_COMM_ACP_Screening_Response_102213_R12.pdf. Accessed 21 Dec 2013.

  • Aneke JC, Adegoke AO, Oyekunle AA, Osho PO, Sanusi AA, Okocha EC, Ibeh NC, Akinola NO, Durosinmi MA. Degrees of kidney disease in Nigerian adults with sickle cell disease. Med Princ Pract. 2014;23:271–4.

    Article  PubMed  Google Scholar 

  • Arogundade FA, Sanusi AA, Hassan MO, Salawu L, Durosinmi MA, Akinsola A. An appraisal of kidney dysfunction and its risk factors in patients with sickle cell disease. Nephron Clin Pract. 2011;118(3):c225-31. doi:10.1159/000321138.

    Article  CAS  PubMed  Google Scholar 

  • Baek SD, Baek CH, Kim JS, Kim SM, Kim JH, Kim SB. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study. Scand J Urol Nephrol. 2012;46:232–8. doi:10.3109/00365599.2011.649045. PMID: 22545920.

    Article  CAS  PubMed  Google Scholar 

  • Ballardie FW, Gartside S, Mallick NP. Computer prediction of the need for dialysis and transplantation using calculated creatinine clearance. Br Med J (Clin Res Ed). 1983;286:1328–31. doi:10.1136/bmj.286.6374.1328. PMID: 6404450.

    Article  CAS  Google Scholar 

  • Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM. 1996;89:415–21.

    Article  CAS  PubMed  Google Scholar 

  • Bolarinwa RA, Akinlade K,S, Kuti M, Olawale OO, Akinola NO. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors. Saudi J Kidney Dis Transpl. 2012;12(23):171–5.

    Google Scholar 

  • Bonomini V, Stefoni S, Vangelista A. Long-term patient and renal prognosis in acute renal failure. Nephron. 1984;36:169–72.

    Article  CAS  PubMed  Google Scholar 

  • Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, et al. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. JAMA. 2014. doi:10.1001/jama.2014.13573. Epub ahead of print.

    PubMed  Google Scholar 

  • Chijioke A, Aderibigbe A, Olarenwaju TO, Makusidi AM, Oguntoyinbo AE. Prevalence and pattern of cystic kidney diseases in Ilorin, Nigeria. Saudi J Kidney Dis Transpl. 2010;21(6):1172–8.

    PubMed  Google Scholar 

  • Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD. Outcomes of stage 3–5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephrol Clin Pract. 2008;109:c109–18. doi:10.1159/000145453. PMID: 18663322.

    Article  Google Scholar 

  • Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23:741–6. doi:10.1093/ndt/gfm836.

    Article  PubMed  Google Scholar 

  • Fary Ka E, Seck SM, Niang A, Cisse MM, Diouf B. Patterns of autosomal dominant polycystic kidney diseases in black Africans. Saudi J Kidney Dis Transpl. 2010;21(1):81–6.

    PubMed  Google Scholar 

  • Firth JD. Acute irreversible renal failure. QJM. 1996;89:397–9.

    Article  CAS  PubMed  Google Scholar 

  • Garg AX, Kurz A, Sessler DI, Cuerden M, Robinson A, et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA. 2014. doi:10.1001/jama.2014.15284. Nov 15, [Epub ahead of print].

    PubMed Central  Google Scholar 

  • Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jo SH, Lee JM, Park J, Kim HS. The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients. Cardiology. 2014;130(1):4–14.

    Article  PubMed  Google Scholar 

  • Johnson A, Gabow P. Identification of patients with autosomal dominant polycystic disease at highest for end stage renal disease. J Am Soc Nephrol. 1997;8:1560–7.

    CAS  PubMed  Google Scholar 

  • Kelleher CL, McFann KK, Johnson AM, Schrier RW. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens. 2004;17(11 Pt 1):1029–34.

    Article  PubMed  Google Scholar 

  • Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol. 1995;5(12):2037–47.

    CAS  PubMed  Google Scholar 

  • Klotman PE. HIV – associated nephropathy. Kidney Int. 1999;56:1161–76.

    Article  CAS  PubMed  Google Scholar 

  • Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38:167–84.

    Article  CAS  PubMed  Google Scholar 

  • Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47. doi:10.7326/0003-4819-139-2-200307150-00013. PMID: 12859163.

    Article  PubMed  Google Scholar 

  • Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52:661–71. doi:10.1053/j.ajkd.2008.06.023. PMID: 18805347.

    Article  CAS  PubMed  Google Scholar 

  • Merino GE, Buselmeier TJ, Kjellstrand CM. Postoperative chronic renal failure: a new syndrome? Ann Surg. 1975;182:37–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moyer VA. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:567–70. doi:10.7326/0003-4819-157-8-201210160-00533. PMID: 22928170.

    Article  PubMed  Google Scholar 

  • National AIDS/HIV/STD Control Programme, Federal Ministry of Health and Social Services. Technical Reports, 1997, 1999, 2000, 2002, 2003.

    Google Scholar 

  • Nielson E, Hennrikus E, Lehman E, Mets B. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery. J Hosp Med. 2014;9(5):283–8. doi:10.1002/jhm.2155. Epub 2014 Jan 24.

    Article  PubMed  Google Scholar 

  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266. PMID: 11904577.

    Google Scholar 

  • Okafor UH, Unuigbe EI, Ojogwu LI, Oviasu E, Wokoma FS. Renal disease in HIV infected patients at University of Benin Teaching Hospital, Nigeria. Afr Health Sci. 2011;11(1):S28–33.

    PubMed  PubMed Central  Google Scholar 

  • Onuigbo MA. The natural history of chronic kidney disease revisited – a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Adv Perit Dial. 2009a;25:85–8. PMID: 19886324.

    PubMed  Google Scholar 

  • Onuigbo MA. Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET – a call for more circumspection. QJM. 2009b;102(3):155–67.

    Article  CAS  PubMed  Google Scholar 

  • Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Ren Fail. 2010;32:954–8. doi:10.3109/0886022X.2010.502608. PMID: 20722563.

    Article  PubMed  Google Scholar 

  • Onuigbo MA. Can ACE, inhibitors and angiotensin receptor blockers be detrimental in CKD patients? Nephrol Clin Pract. 2011;118(4):c407–19. doi:10.1159/000324164. Epub 2011 Mar 7.

    Article  CAS  Google Scholar 

  • Onuigbo MA. CKD Express © – a new IT-software proposed for a paradigm change in CKD care. Open Med Inf J. 2012;6:26–7.

    Article  Google Scholar 

  • Onuigbo MA. The CKD enigma with misleading statistics and myths about CKD, and conflicting ESRD and death rates in the literature: results of a 2008 U.S. population-based cross-sectional CKD outcomes analysis. Ren Fail. 2013a;35:338–43. doi:10.3109/0886022X.2013.764272. PMID: 23391263.

    Article  PubMed  Google Scholar 

  • Onuigbo MAC. Nondialytic therapy for end-stage renal disease is an underutilized care paradigm in the United States: time for a more robust reappraisal of this treatment option. Adv Perit Dial. 2013b;29:73–6.

    PubMed  Google Scholar 

  • Onuigbo MA. Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature – preventable causes of AKI and SORO-ESRD – a call for re-engineering of nephrology practice paradigms. Ren Fail. 2013c;35(6):796–800. doi:10.3109/0886022X.2013.800459. Epub 2013 Jun 3.

    Article  CAS  PubMed  Google Scholar 

  • Onuigbo MA. Syndrome of rapid-onset end-stage renal disease in two consecutive renal transplant recipients. Indian J Nephrol. 2013d;23:222–5. doi:10.4103/0971-4065.111861. PMID: 23814425.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Onuigbo MA. Renoprevention: a new concept for reengineering nephrology care – an economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Ren Fail. 2013e;35(1):23–8.

    Article  CAS  PubMed  Google Scholar 

  • Onuigbo MA. Renoprevention: a new concept for reengineering nephrology care – an economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Ren Fail. 2013f;35(1):23–8. doi:10.3109/0886022X.2012.741644. Epub 2012 Nov 15.

    Article  CAS  PubMed  Google Scholar 

  • Onuigbo MA. Renoprevention revisted – the impact of preemptive withdrawal of RAAS blockade prior to iodinated contrast exposure in older CKD patients: results of a new meta-analysis. Cardiology. 2014a;130(1):25–6.

    Article  PubMed  Google Scholar 

  • Onuigbo MA. Preoperative angiotensin axis blockade therapy, intraoperative hypotension, and the risks of postoperative acute kidney injury. J Hosp Med. 2014b;9(9):610. doi:10.1002/jhm.2229. Epub ahead of print.

    Article  PubMed  Google Scholar 

  • Onuigbo MA, Achebe NJ. Acute kidney injury on chronic kidney disease – the rainbow syndrome of too many colors: a Mayo Clinic Health System case series report. In: Onuigbo MAC, editor. ACE inhibitors: medical uses, mechanisms of action, potential adverse effects and related topics, vol. 1. New York: NOVA Publishers; 2013. p. 91–108.

    Google Scholar 

  • Onuigbo M, Agbasi N. Medicare and the escalating costs of US ESRD care compared with the United Kingdom National Health Service: a case study of reengineering current US CDC hepatitis B virus testing protocols among hemodialysis patients to achieve cost savings – the use of a new IT software program, the CKD Express ©, to achieve cost-effective CKD care for the US Medicare. In: Berhardt LV, editor. Advances in medicine and biology, vol. 76. New York: Nova Publishers; 2014a. p. 21–38.

    Google Scholar 

  • Onuigbo M, Agbasi N. “Quadruple whammy” – a preventable newly described syndrome of post-operative AKI in CKD II and CKD III patients on combination “Triple Whammy” medications: a Mayo Clinic Health System, Eau Claire, Wisconsin experience. Niger J Clin Pract. 2014b;17(5):649–54.

    Article  CAS  PubMed  Google Scholar 

  • Onuigbo M, Agbasi N. Chronic kidney disease prediction is an inexact science: the concept of “progressors” and “nonprogressors”. World J Nephrol. 2014c;3(3):31–49.

    Article  PubMed  PubMed Central  Google Scholar 

  • Onuigbo M, Agbasi N. Escalating cost of pre-dialysis chronic kidney disease care in the US: the introduction of an innovative chronic kidney disease care paradigm using “The CKD Express © IT Software Program” – a new recommended tool for medicare and the affordable care act. Open Med Inf J. 2014. (In Print).

    Google Scholar 

  • Onuigbo MA, Onuigbo NT. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience. Med Sci Monit. 2005;11:CR462–9. PMID: 16192897.

    CAS  PubMed  Google Scholar 

  • Onuigbo M, Onuigbo N, editors. Chronic kidney disease and RAAS blockade: a new view of renoprotection. London: Lambert Academic Publishing; 2011.

    Google Scholar 

  • Onuigbo MA, Onuigbo NT. The syndrome of rapid onset end-stage renal disease (SOROESRD) – a new Mayo Clinic dialysis services experience, January 2010–February 2011. In: Di Iorio B, Heidland A, Onuigbo M, Ronco C, editors. Hemodialysis: when, how, why. New York: Nova Publishers; 2012. p. 443–85.

    Google Scholar 

  • Onuigbo MA, Onuigbo NTC. A second case of “Quadruple Whammy” in a week in a Northwestern Wisconsin hospital. BMJ. 2013. Rapid Response, Published online 1 Mar 2013. http://www.bmj.com/content/346/bmj.f678/rr/633687

  • Onuigbo MA, Ozoh JO, Egbuji T, Ijeoma CK, Chukwuka C, Offodile AA, Obianigwe V. Adult polycystic kidney disease. A Nigerian family study. Niger Med J. 1991;3(4):71–3.

    Google Scholar 

  • Onuigbo MA, Onuigbo C, Onuigbo V, Onuigbo M, Onuigbo N, Joshi M, Egbuniwe O. The CKD enigma, reengineering CKD care, narrowing asymmetric information and confronting ethicomedicinomics in CKD care: the introduction of the new ‘CKD express©’ IT software program. In: Onuigbo MAC, editor. ACE inhibitors: medical uses, mechanisms of action, potential adverse effects and related topics, vol. 1. New York: NOVA Publishers; 2013a. p. 41–56.

    Google Scholar 

  • Onuigbo MA, Onuigbo NTC. “Quadruple Whammy”, a new syndrome of potentially preventable yet iatrogenic acute kidney injury in the ICU. BMJ. 2013. Rapid Response, Published online 25 Feb 2013. http://www.bmj.com/content/346/bmj.f678/rr/632570

  • Onuigbo MA, Roman-Maradiaga BP, Achebe NJ. “Quadruple Whammy” – a newly described preventable syndrome of peri-operative AKI on CKD in patients on concurrent “Triple Whammy” medications. In: Onuigbo MAC, editor. ACE inhibitors: medical uses, mechanisms of action, potential adverse effects and related topics, vol. 1. New York: Nova Publishers; 2013c. p. 63–74.

    Google Scholar 

  • Onuigbo MA, Achebe NJ, Musso CG. The syndrome of rapid onset ESRD in the last 100 consecutive incident Northwestern Wisconsin Mayo Clinic chronic hemodialysis patients, 2010–2011: results of the analysis of individual patient-level serum creatinine trajectories to ESRD – can there be a link with angiotensin inhibition and renal senescence in older CKD patients? In: Onuigbo MAC, editor. ACE inhibitors: medical uses, mechanisms of action, potential adverse effects and related topics, vol. 1. New York: Nova Publishers; 2013d. p. 109–25.

    Google Scholar 

  • Onuigbo MA, Onuigbo NT, Musso CG. Syndrome of rapid onset end stage renal disease in incident Mayo Clinic chronic hemodialysis patient. Indian J Nephrol. 2014;24:75–81. doi:10.4103/0971-4065.127886. PMID:24701038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease, life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–44.

    Article  CAS  PubMed  Google Scholar 

  • Ponte B, Felipe C, Muriel A, Tenorio MT, Liano F. Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrol Dial Transplant. 2008;23:3859–66.

    Article  PubMed  Google Scholar 

  • Powars DR, Elliot – Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course and mortality. Ann Intern Med. 1991;115:614–20.

    Article  CAS  PubMed  Google Scholar 

  • Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int. 1977;11:62–70. doi:10.1038/ki.1977.8. PMID: 839654.

    Article  CAS  PubMed  Google Scholar 

  • Shah BV, Levey AS. Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope. J Am Soc Nephrol. 1992;2:1186–91. PMID: 1591359.

    CAS  PubMed  Google Scholar 

  • Sikaneta T, Abdolell M, Taskapan H, Roscoe J, Fung J, Nagai G, Ting RH, Ng P, Wu G, Oreopoulos D, Tam PY. Variability in CKD stage in outpatients followed in two large renal clinics. Int Urol Nephrol. 2012;44:1461–6. doi:10.1007/s11255-011-9934-9. PMID: 21424573.

    Article  PubMed  Google Scholar 

  • Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343–60.

    Article  PubMed  Google Scholar 

  • Taylor EH. Clinical chemistry. New York: Wiley; 1989. p. 58–62. 4.

    Google Scholar 

  • United States Renal Data System (USRDS). Annual Reports. National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health. Bethesda, MD, 1992, 1994, 1995, 1996, 1997, 1998, 1999.

    Google Scholar 

  • Wald R, Quinn RR, Luo J, Li P, Li P, Scales DC, Mamdani MM, Ray JG. University of Toronto Acute Kidney Injury Research Group: chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009;302:1179–85.

    Article  CAS  PubMed  Google Scholar 

  • Walser M, Drew HH, LaFrance ND. Reciprocal creatinine slopes often give erroneous estimates of progression of chronic renal failure. Kidney Int Suppl. 1989;27:S81–5. PMID:2700001.

    CAS  PubMed  Google Scholar 

  • Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 2003;63:1618–31.

    Article  PubMed  Google Scholar 

  • Weis L, Metzger M, Haymann JP, Thervet E, Flamant M, Vrtovsnik F, Gauci C, Houillier P, Froissart M, Letavernier E, Stengel B, Boffa JJ. Renal function can improve at any stage of chronic kidney disease. PLoS ONE. 2013;8:e81835. doi:10.1371/journal.pone.0081835. PMID:24349134.

    Article  PubMed  PubMed Central  Google Scholar 

  • Winkelmayer WC, Finkel KW. Prevention of acute kidney injury using vasoactive or antiplatelet treatment: three strikes and out? JAMA. 2014. doi:10.1001/jama.2014.14548. Nov 15, [Epub ahead of print].

    Google Scholar 

  • Winston JA, Burns GC, Klotman PE. The immunodeficiency virus (HIV) epidemic and HIV- associated nephropathy. Semin Nephrol. 1998;18:373–7.

    CAS  PubMed  Google Scholar 

  • Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107–213.

    CAS  PubMed  Google Scholar 

  • Yach D, Calitz C. New opportunities in the changing landscape of prevention. JAMA. 2014;312(8):791–2. doi:10.1001/jama.2014.8900.

    Article  CAS  PubMed  Google Scholar 

  • Yersin C, Bovet P, Wauters JP, Schorderet DF, Pescia G, Paccaud F. Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant. 1997;12(10):2069–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA

    Macaulay Onuigbo

  2. Department of Nephrology, Mayo Clinic Health System, 1221 Whipple Street, Eau Claire, WI, 54702, USA

    Macaulay Onuigbo

  3. North East London NHS Foundation Trust, Barley Lane, Ilford, Essex, 1G3 8XJ, UK

    Nneoma Agbasi

  4. Department of Medicine, Nnamdi Azikiwe Teaching Hospital, C/o PMB 5025, Awka, Nigeria

    Ogonna Oguejiofor, Emmanuel Okocha, Chinawaeze Aneke & Charles Odenigbo

Authors
  1. Macaulay Onuigbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nneoma Agbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ogonna Oguejiofor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emmanuel Okocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chinawaeze Aneke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Charles Odenigbo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Macaulay Onuigbo .

Editor information

Editors and Affiliations

  1. DeptofBiomedlSci,FacltyofSci&Technology, University of Westminster , London, United Kingdom

    Vinood B. Patel

  2. Department of Nutrition and Dietetics,Division of Diabetes and Nutritional Sciences, Faculty of Life Science and Medicine, King’s College London, London, United Kingdom

    Victor R. Preedy

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this entry

Cite this entry

Onuigbo, M., Agbasi, N., Oguejiofor, O., Okocha, E., Aneke, C., Odenigbo, C. (2016). Serum Creatinine Trajectories in Kidney Disease. In: Patel, V., Preedy, V. (eds) Biomarkers in Kidney Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7699-9_9

Download citation

Publish with us

Policies and ethics

Search

Navigation